Union Pacific Shares Fall After Lowered Annual Volume Growth Forecast

Union Pacific Corporation (NYSE:UNP) posted Q3 FY22 adjusted EPS of $3.19, beating the consensus of $3.08 and better than the…
  • Union Pacific Corporation (NYSE:UNP) posted Q3 FY22 adjusted EPS of $3.19, beating the consensus of $3.08 and better than the $2.57 posted a year ago.
  • Union Pacific included a $114 million charge for a change to prior-period accounting estimates related to new, tentative, and ratified labor agreements.
  • Operating revenue of $6.6 billion was up 18%, driven by higher fuel surcharge revenue, volume growth, and core pricing gains. The consensus estimate for sales is $6.42 billion.
  • Business volumes, as measured by total revenue carloads, were up 3%.
  • Union Pacific’s reported operating ratio was 59.9%. Excluding the charge, the adjusted operating ratio of 58.2% deteriorated by 190 basis points. Lower fuel prices positively impacted the operating ratio by 70 basis points.
  • Adjusted operating income of $2.7 billion was up 13%.
  • Guidance: Union Pacific trimmed its full-year volume growth forecast to about 3% from a prior estimate of 4% – 5%.
  • It expects an FY22 operating ratio of around 60%
  • Price Action: UNP shares are down 3.97% at $192.12 during the premarket session on the last check Thursday.
Total
0
Shares
Related Posts
Read More

Sonnet BioTherapeutics Announces Pharmacokinetic And Pharmacodynamic Data In A Phase 1 Dose-Escalation Trial Of SON-1010; Says ‘PK data shows an extended half-life of SON-1010 of approximately 112 hours, compared to 12 hours for rhIL-12’

24 healthy volunteers have been dosed in study SB102 to assess the safety, PK, and PD of SON-1010 without the background of prior chemotherapy PK data shows an extended half-life of SON-1010 of approximately 112

SONN